Drugs Made IN America Acquisition Corp (DMAAU)
Drugs Made IN America Acquisition Corp (DMAAU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | DMAAU | ||||
| Company | Drugs Made IN America Acquisition Corp | ||||
| Price Information | |||||
| Exchange | NASDAQ | ||||
| Open | 11.32 | ||||
| High | 11.32 | ||||
| Low | 11.32 | ||||
| Latest | 11.32 | ||||
| Change | +0.63 | ||||
| % Change | +5.89% | ||||
| Volume | 1,400 | ||||
| 20-Day Average Volume | 5,875 | ||||
| Previous Close | 10.69 | ||||
| Industry | N/A | ||||
| Has Options | No | ||||
| Technicals | |||||
| 20-Day Moving Average | 10.67 | ||||
| 20-Day Raw Stochastic | 43.00% | ||||
| 20-Day Relative Strength | 65.72 | ||||
| Weighted Alpha | +12.18 | ||||
| Today's Opinion | N/A | ||||
| Previous Opinion | N/A | ||||
| Last Month's Opinion | N/A | ||||
| Performance | |||||
| 5-Days | |||||
| %Chg | +5.40% since 05/27/26 | ||||
| Low | 10.69 on 06/05/26 | ||||
| High | 11.90 on 06/02/26 | ||||
| 1-Month | |||||
| %Chg | +6.99% since 04/08/26 | ||||
| Low | 10.69 on 06/05/26 | ||||
| High | 12.50 on 05/22/26 | ||||
| 3-Month | |||||
| %Chg | +7.81% since 02/27/26 | ||||
| Low | 10.43 on 04/07/26 | ||||
| High | 12.50 on 05/22/26 | ||||
| 6-Month | |||||
| %Chg | +8.12% since 12/08/25 | ||||
| Low | 10.43 on 04/07/26 | ||||
| High | 12.50 on 05/22/26 | ||||
| Key Statistics | |||||
| Market Capitalization, $K | N/A | ||||
| Shares Outstanding, K | N/A | ||||
| Annual Sales | 0 | ||||
| Annual Net Income | 5,940,643 | ||||
| Last Quarter Sales | 0 | ||||
| Last Quarter Net Income | 1,970,459 | ||||
| 60-Month Beta | N/A | ||||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | ||||
| Earnings Date | N/A | ||||
| Most Recent Dividend | N/A | ||||
| Next Ex-Dividends Date | N/A | ||||
| Ratios | |||||
| Price/Earnings ttm | N/A | ||||